ALPHALEX
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Nov 2022)
What this means for you
This application is over — abandoned 28 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88197341
- Mark type
- Stylized text
- Filed
- 16 Nov 2018
- Published for opposition
- 27 Aug 2019
- Abandoned
- 28 Nov 2022
- Attorney of record
- David Ewen
Goods and services
- Class 005 — Pharmaceuticals: Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment
Owner
- Cybrexa, Inc., New Haven, CT, US
- Cybrexa, Inc., New Haven, CT, US
Prosecution history
- 28 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2022 — SOU EXTENSION 5 GRANTED
- 28 Mar 2022 — SOU EXTENSION 5 FILED
- 01 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Feb 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Feb 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2021 — SOU EXTENSION 4 GRANTED